News|Articles|November 18, 2025
Understanding Anti-Drug Antibody Assessment: Early Discovery through Clinical Trials
Author(s)Prolytix
Key Takeaways
Learn the unique considerations for use of ADA assays in early development, pre-clinical and clinical settings, as well as how to generate high-quality methods at each stage to support successful development and regulatory approval of safe and effective biotherapeutic drugs.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Implications on SMA Care of High-Dose Nusinersen
2
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
3
How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve
4
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
5
